Shareholders meeting

September 29, 2026 The Manager, Listing Department BSE Limited The National Stock Exchange of India Ltd. Corporate Relationship Department, Exchange Plaza, Bandra Kurla Complex, Phiroze Jeejeebhoy Towers, Bandra (E), Mumbai - 400 051 Dalal Street, Mumbai - 400 001 NSE Symbol : PANACEABIO BSE Scrip Code: 531349 Sub.: Proceedings of the 42nd Annual General Meeting held on September 29, 2026 Ref: Disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, Pursuant to the provisions of Regulation 30 read with Para A of Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”), please find enclosed herewith the proceedings of the 42nd Annual General Meeting (“AGM”) of the Company held on Tuesday, September 29, 2026 at 11:30 A.M. through Video Conferencing (“VC”). The detailed voting results of all the businesses transacted at the AGM as set out in the AGM Notice along with the consolidated Scrutinizer’s Report as required under Regulation 44 of the SEBI LODR Regulations shall be submitted in due course of time. This is for your information and record please. Thanking You, Sincerely yours, For Panacea Biotec Limited Ankit Jain General Manager – Legal & Company Secretary Encl.: As Above Panacea Biotec Limited (CIN: L33117PB1984PLC022350) Regd. Office : Ambala Chandigarh Highway, Lalru – 140501, Punjab Correspondence/Corporate office : B-1 Extn./A-27, Mohan Co-op. Indl. Estate, Mathura Road, New Delhi - 110 044, India Ph.: 91-11-4167 9000, 4167 8000, Fax: 91-11-4167 9070 Email: companysec@panaceabiotec.com GIST OF PROCEEDINGS OF THE 42ND ANNUAL GENERAL MEETING OF PANACEA BIOTEC LIMITED HELD ON TUESDAY, SEPTEMBER 29, 2026 The 42nd Annual General Meeting (“AGM” or “Meeting”) of the Members of Panacea Biotec Limited (the “Company”) has been held today i.e. Tuesday, September 29, 2026 commenced at 11:30 A.M. through Video Conferencing (“VC”), in accordance with the applicable provisions of the Companies Act, 2013 (“Act”) read with the rules issued thereunder, the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI LODR Regulations”) and the General Circulars issued by the Ministry of Corporate Affairs & Securities and Exchange Board of India. The proceedings of the AGM were deemed to be conducted at the Registered Office of the Company viz. Ambala-Chandigarh Highway, Lalru - 140501, Punjab, India which was the deemed venue for the AGM. The following Directors and Officials of the Company, inter-alia, attended the meeting: 1. Mr. Sandeep Jain, Joint Managing Director and Member of inter-alia, Stakeholders’ Relationship Committee, Risk Management Committee as well as Promoter Shareholder of the Company 2. Dr. Sanjay Trehan, Director Technical & Compliances and Member of Stakeholders’ Relationship Committee & Risk Management Committee 3. Mrs. Ambika Sharma, Independent Director and Chairman of Nomination & Remuneration Committee and Stakeholders’ Relationship Committee 4. Mr. Krishan Kumar Jalan, Independent Director, Chairman of Audit Committee and Member of Nomination & Remuneration Committee 5. Dr. Rajender Pal Singh, Independent Director and Member of Audit Committee, Nomination & Remuneration Committee and Risk Management Committee 6. Mr. Rajinder Singh Manku, Independent Director and Member of Audit Committee 7. Dr. Venkatesh Savasiddhi, Independent Director 8. Mr. Vinod Goel, Group CFO and Head Legal & Corporate Governance 9. Dr. Khalid Ali Syed, Chief Scientific Officer 10. Mr. Ankit Jain, General Manger - Legal & Company Secretary and Compliance Officer 11. Mr. Amit Saraswat, General Manager – Business & Operating Finance 12. Mr. Amit Gupta, General Manager – Accounts & Taxation 13. Ms. Ritu Dhyani, Manager – Secretarial & Compliance The meeting started with the welcome address by the Company Secretary. The Company Secretary then informed that the sufficient members to form quorum, have attended the meeting through VC and were present throughout the meeting and accordingly the Meeting was called to order. Since Dr. Rajesh Jain, Chairman and Managing Director of the Company could not attend the meeting due to other pre-occupation, Mr. Krishan Kumar Jalan, Independent Director was elected as Chairman of the Meeting. Page 1 of 4 GIST OF PROCEEDINGS OF THE 42ND ANNUAL GENERAL MEETING OF PANACEA BIOTEC LIMITED HELD ON TUESDAY, SEPTEMBER 29, 2026 The members were informed that Mr. Ankesh Jain and Mr. Harshet Jain, Whole-time Directors of the Company, also could not attend the meeting due to their other prior commitments / engagements. Mr. Kapil Kedar, Partner and Mr. Raman Goyal, Assistant General Manager of M/s Suresh Surana & Associates LLP, Chartered Accountants, Statutory Auditors of the Company, were also present in the meeting through VC. Mr. Debabrata Deb Nath, Partner, M/s R&D Company Secretaries, Secretarial Auditors of the Company also attended the meeting through VC. He was appointed as Scrutinizer to scrutinize the remote e-voting process & e-voting at the AGM in a fair & transparent manner. The Company Secretary further informed that pursuant to the applicable provisions of the Act and rules enacted thereunder read with the SEBI LODR Regulations and SS-2 i.e. Secretarial Standards on General Meeting, issued by the Institute of Company Secretaries of India, the Company had provided the remote e-voting facility to the members of the Company who were members as on the cut-off date viz. Tuesday, September 22, 2026 for casting their votes electronically in respect of the resolutions as contained in the AGM Notice. Remote e-voting commenced at 09:00 A.M. IST on Saturday, September 26, 2026, and ended at 05:00 P.M. IST on Monday, September 28, 2026. He further informed that only those members who have not cast their votes via remote e-voting can exercise their right to vote through e-voting at the AGM, which started at 11:30 A.M. and shall remain open for 30 minutes after the conclusion of AGM. The requisite Statutory Registers under the Act, Auditors’ Report, Secretarial Audit Report & other documents were available for inspection electronically by the members during the meeting. He further informed that the Notice of AGM and Annual Report of the Company for the financial year ended March 31, 2026, were taken as read as the same were already circulated to the members. The Report of the Statutory Auditors was not required to be read as it did not contain any qualification(s) / reservation / adverse remark(s) on the Financial Statements for the year which ended on March 31, 2026. The management’s response to the observation / comment / key audit matters contained in the Statutory Auditors’ Report and Annexure thereto has been suitably provided in the respective Notes to the Financial Statements referred to therein and in the Directors’ Report. The Report of the Secretarial Auditors was also not required to be read as it did not contain any qualification(s) / reservation / adverse remark(s). However, the Secretarial Audit report contains two observations which have suitably been responded to in the Directors’ Report. He thereafter requested Mr. Krishan Kumar Jalan, Chairman to deliver the speech briefly highlighting recent significant developments and the financial highlights of the Company during Page 2 of 4 GIST OF PROCEEDINGS OF THE 42ND ANNUAL GENERAL MEETING OF PANACEA BIOTEC LIMITED HELD ON TUESDAY, SEPTEMBER 29, 2026 the financial year ended March 31, 2026 & quarter ended June 30, 2026 along with the steps being taken to achieve growth in the performance of the Company. Thereafter, the following items of business as set out in the AGM Notice were taken up for the Shareholder’s approval: Ordinary Business 1. Consider and adopt: a) the Audited Standalone Financial Statements of the Company for the financial year ended March 31, 2026, together with the reports of the Board of Director [Showing first 8,000 characters — download PDF for full document]